2009-10-26 19:29:04 - Eisai Co., Ltd. - SWOT Analysis - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/eisai-co.,-l ..

This Eisai Co., Ltd. Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Eisai is engaged in the manufacturing and marketing of drugs, chemicals and food additives. The company primarily operates in Japan, North America, Europe and Asia. It is headquartered in Tokyo, Japan and employs about 10,700 people. The company recorded revenues of JPY734,286 million (approximately $6,447 million) during the financial year (FY) ended March 2008, an increase of 8.9% over 2007. The revenue increase in FY2008 was mainly due to the growth in the sales of Aricept and AcipHex/Pariet. The operating

 

 

profit of the company was JPY17,749 million (approximately $155.8 million) during FY2008, a decrease of 83.1% over 2007. The net loss was JPY17,012 million (approximately $149.4 million) in FY2008, as compared to a net profit of JPY70,614 million (approximately $619.9 million) over 2007.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available